Table 2.
Epinephrine day | Gly/Gly | Arg/Arg | P value |
---|---|---|---|
Plasma epinephrine concentration (pg/mL)5 | |||
Basal | 34 ± 5 | 26 ± 3 | 0.33 |
Epi #1 | 108 ± 7 | 103 ± 7 | 0.65 |
Resting | 33 ± 4 | 24 ± 4 | 0.39 |
Epi #2 | 543 ± 39 | 504 ± 37 | 0.91 |
Plasma norepinephrine concentration (pg/mL)* | |||
Basal | 142 ± 16 | 128 ± 16 | 0.73 |
Epi #1 | 148 ± 10 | 153 ± 12 | 0.47 |
Resting | 140 ± 14 | 135 ± 14 | 0.92 |
Epi #2 | 205 ± 21 | 189 ± 12 | 0.59 |
Values are mean ± SEM. Epi #1, epinephrine infusion at rate of 5 ng kg−1 min−1; Epi #2, epinephrine infusion at rate of 40 ng kg−1 min−1. There were no significant differences between Gly/Gly and Arg/Arg subjects.
n =14 in Gly/Gly and n =15 in Arg/Arg groups.